search
Back to results

Effects of StellaLife Oral Care Recovery Kit on Palatal Wound Healing After Free Gingival Graft

Primary Purpose

Wound Heal

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Free Gingival Graft Procedure
Sponsored by
Louisiana State University Health Sciences Center in New Orleans
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Wound Heal focused on measuring Inadequate Keratinized Gingiva, Mouthrinse

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Adults aged ≥18 years, No history of medication affecting periodontal status in the last 6 months, No history of allergy to study medication or material, No use of tobacco, No history of pregnancy or lactation or contraceptive medication Good oral hygiene. Exclusion Criteria: Previous palatal surgery Patient on anticoagulant therapy Uncontrolled diabetes, Rheumatoid arthritis, Osteoporosis.

Sites / Locations

  • LSUHSC School of Dentistry

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Placebo Comparator

Experimental

Active Comparator

Arm Label

NC Group

S Group

C Group

Arm Description

This group is provided normal saline mouth-rinse to rinse 2 times per day along with placebo gel to be applied 2 times and placebo oral spray.

This group is provided StellaLife Oral Care kit's mouth-rinse, gel and spray 2 times per day.

This group is provided chlorhexidine mouth-rinse and placebo gel and spray 2 times per day.

Outcomes

Primary Outcome Measures

Wound Healing Estimation
Clinical photographs of the donor site will be taken at baseline, immediately after surgery, and at each follow-up visit, to record the appearance A sterile paper measuring tape in millimeters will be placed on the length and width of the wound at the time getting the picture, then with use of the image analysis software the size (area in sq millimeter) and wound healing estimation will be made. The images will be analyzed with ImageJ software to determine area.

Secondary Outcome Measures

Epithelization Assessment
A wound epithelization test will be done with hydrogen peroxide on each follow-up visits to record epithelization. The wound will be dried with gentle air flow and 3% hydrogen peroxide will be sprayed with a syringe. The appearance of bubbles will be considered as indication for incomplete epithelialization and will be dichotomously recorded (yes/no).
Wound Exudate assessment
The wound exudate sample will be collected using a sterile durapore membrane. The membrane would be held on the surface of the wound for 30 seconds to absorb the wound exudate and then transferred to 2ml plastic vial. All samples will be at -40 degree centigrade till further analysis. Expression of cytokine biomarkers and metabolomes will be analyzed in picogram/mL
Wound Plaque assessment
Plaque samples over the wound will be collected using sterile Q tips. The Q-tips will be transferred into plastic vials containing 50 ul RNA latter. All samples will be at -40 degree centigrade till further analysis. The de-identified plaque samples would be sent to the lab for DNA isolation and high through output sequencing of bacterial genomes to measure the relative abundance of different bacterial phyla and classes
Oral Health Impact Profile-14
The oral health-related quality of life will be assessed by the Oral Health Impact Profile scale (OHIP-14). Participants will be asked how frequently they had experienced the impact on each category in OHIP-14 with a 5-point scale (from 0 to 4). The total score of OHIP-14 will be calculated by adding the sum of each category from 14 questions (total score ranges from 0 to 56 points). Higher scores imply a poorer oral health quality of life, whereas lower scores indicate a better one.
Functional Pain Scale
The patient experienced pain and discomfort will be assessed and by the Functional Pain Scale. Participants will be asked to rate their pain on a scale of 0 to 5. The scale will also be used to assess pain and questions related to analgesic use and postoperative discomfort and complications experienced. Highest score of 5 is intolerable pain and score of 0 is no pain.

Full Information

First Posted
May 3, 2023
Last Updated
June 19, 2023
Sponsor
Louisiana State University Health Sciences Center in New Orleans
search

1. Study Identification

Unique Protocol Identification Number
NCT05921513
Brief Title
Effects of StellaLife Oral Care Recovery Kit on Palatal Wound Healing After Free Gingival Graft
Official Title
Effects of StellaLife Oral Care Recovery Kit on Palatal Wound Healing After Free Gingival Graft
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 15, 2023 (Anticipated)
Primary Completion Date
July 30, 2024 (Anticipated)
Study Completion Date
July 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Louisiana State University Health Sciences Center in New Orleans

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study looks to compare the clinical effects of StellaLife VEGA Oral Care Kit with chlorhexidine mouth-rinse on patient comfort, wound healing, wound epithelialization, bacterial levels, and colonization of the wounds.
Detailed Description
A total of 60 participants will be recruited from those needing and have been treatment planned for a free gingival graft surgery to increase keratinized gum. The study subjects will be randomly allocated to either negative control group (NC), chlorhexidine group (C) or StellaLife group (S) by randomization done using a computer-generated table. The NC group is provided normal saline mouth-rinse to rinse 2 times per day along with placebo gel to be applied 2 times and placebo oral spray. The S group will use StellaLife Oral Care mouth-rinse, gel and spray 2 times per day. The C group will use chlorhexidine mouth-rinse and placebo gel and spray 2 times per day. All groups beginning the same day and continuing for the duration of two weeks. All patients will receive a protective splint. Following this, subjective and objective measurements on the success of the mouthwash and oral care kit will be measured. Patients will be evaluated post operatively following surgery as mentioned below: Wound Healing Assessment and Epithelization Assessment: Postoperative Days 1, 5, 14, 21 and 28 Oral Health Impact Profile-14 and Functional Pain Scale: Starting on the day of the surgery and Postoperative Days 1, 5, 14, 21 and 28 Wound Exudate assessment: Samples collected on Postoperative Days 1, 5, 14, 21 and 28 Wound Plaque assessment: Starting on the day of the surgery and Postoperative Days 1, 5, 14, 21 and 28

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Heal
Keywords
Inadequate Keratinized Gingiva, Mouthrinse

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Parallel model: Patient will receive either normal saline mouth-rinse to rinse, or Chlorhexidine mouth-rinse with placebo gel and placebo oral spray or Stellalife Oral Care Kit with mouthrinse, gel and oral spray.
Masking
Participant
Masking Description
The participants will be masked to which mouth-rinse, gel and spray they are receiving.
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
NC Group
Arm Type
Placebo Comparator
Arm Description
This group is provided normal saline mouth-rinse to rinse 2 times per day along with placebo gel to be applied 2 times and placebo oral spray.
Arm Title
S Group
Arm Type
Experimental
Arm Description
This group is provided StellaLife Oral Care kit's mouth-rinse, gel and spray 2 times per day.
Arm Title
C Group
Arm Type
Active Comparator
Arm Description
This group is provided chlorhexidine mouth-rinse and placebo gel and spray 2 times per day.
Intervention Type
Procedure
Intervention Name(s)
Free Gingival Graft Procedure
Intervention Description
This procedure is done to increase the width of keratinized gingiva around teeth or dental implant. The healing of the palatal wound at the donor site will be recorded.
Primary Outcome Measure Information:
Title
Wound Healing Estimation
Description
Clinical photographs of the donor site will be taken at baseline, immediately after surgery, and at each follow-up visit, to record the appearance A sterile paper measuring tape in millimeters will be placed on the length and width of the wound at the time getting the picture, then with use of the image analysis software the size (area in sq millimeter) and wound healing estimation will be made. The images will be analyzed with ImageJ software to determine area.
Time Frame
Samples collected on Postoperative days: day 1, day 5, day 14, day 21 and day 28
Secondary Outcome Measure Information:
Title
Epithelization Assessment
Description
A wound epithelization test will be done with hydrogen peroxide on each follow-up visits to record epithelization. The wound will be dried with gentle air flow and 3% hydrogen peroxide will be sprayed with a syringe. The appearance of bubbles will be considered as indication for incomplete epithelialization and will be dichotomously recorded (yes/no).
Time Frame
Samples collected on Postoperative days: day 1, day 5, day 14, day 21 and day 28
Title
Wound Exudate assessment
Description
The wound exudate sample will be collected using a sterile durapore membrane. The membrane would be held on the surface of the wound for 30 seconds to absorb the wound exudate and then transferred to 2ml plastic vial. All samples will be at -40 degree centigrade till further analysis. Expression of cytokine biomarkers and metabolomes will be analyzed in picogram/mL
Time Frame
Starting on the day of the surgery and Postoperative Days: day 1, day 5, day 14, day 21 and day 28
Title
Wound Plaque assessment
Description
Plaque samples over the wound will be collected using sterile Q tips. The Q-tips will be transferred into plastic vials containing 50 ul RNA latter. All samples will be at -40 degree centigrade till further analysis. The de-identified plaque samples would be sent to the lab for DNA isolation and high through output sequencing of bacterial genomes to measure the relative abundance of different bacterial phyla and classes
Time Frame
Starting on the day of the surgery and Postoperative Days: day 1, day 5, day 14, day 21 and day 28
Title
Oral Health Impact Profile-14
Description
The oral health-related quality of life will be assessed by the Oral Health Impact Profile scale (OHIP-14). Participants will be asked how frequently they had experienced the impact on each category in OHIP-14 with a 5-point scale (from 0 to 4). The total score of OHIP-14 will be calculated by adding the sum of each category from 14 questions (total score ranges from 0 to 56 points). Higher scores imply a poorer oral health quality of life, whereas lower scores indicate a better one.
Time Frame
Starting on the day of the surgery and Postoperative Days: day 1, day 5, day 14, day 21 and day 28
Title
Functional Pain Scale
Description
The patient experienced pain and discomfort will be assessed and by the Functional Pain Scale. Participants will be asked to rate their pain on a scale of 0 to 5. The scale will also be used to assess pain and questions related to analgesic use and postoperative discomfort and complications experienced. Highest score of 5 is intolerable pain and score of 0 is no pain.
Time Frame
Starting on the day of the surgery and Postoperative Days: day 1, day 5, day 14, day 21 and day 28

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adults aged ≥18 years, No history of medication affecting periodontal status in the last 6 months, No history of allergy to study medication or material, No use of tobacco, No history of pregnancy or lactation or contraceptive medication Good oral hygiene. Exclusion Criteria: Previous palatal surgery Patient on anticoagulant therapy Uncontrolled diabetes, Rheumatoid arthritis, Osteoporosis.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Vinayak Joshi, MS
Phone
504-941-8280
Email
vjosh1@lsuhsc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Amber Kreko, DDS
Email
akreko@lsuhsc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vinayak Joshi
Organizational Affiliation
LSUHSC, School of Dentistry, New Orleans, LA
Official's Role
Principal Investigator
Facility Information:
Facility Name
LSUHSC School of Dentistry
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70119
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Vinayak Joshi, MS, PhD
Email
vjosh1@lsuhsc.edu
Ext
Joshi
Email
vjosh1@lsuhsc.edu
First Name & Middle Initial & Last Name & Degree
Vinayak Joshi, MS,Phd
First Name & Middle Initial & Last Name & Degree
Eswar Kandaswamy, MS
First Name & Middle Initial & Last Name & Degree
Panos Dragonas, MS
First Name & Middle Initial & Last Name & Degree
Amber Kreko, DDS

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Aggregated data will be made available at the time of publication

Learn more about this trial

Effects of StellaLife Oral Care Recovery Kit on Palatal Wound Healing After Free Gingival Graft

We'll reach out to this number within 24 hrs